BioCorRx Inc. (BICX) is the 272nd largest of 297 Pharmaceuticals companies by market capitalisation, at 3.46 Mn, behind Cadrenal Therapeutics, Inc. at 3.76 Mn. The table below compares all 297 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 670.47 Bn | 31.87 | 6.85 | 649.71 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 461.14 Bn | 73.01 | 7.16 | 454.57 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 376.50 Bn | 118.81 | 5.66 | 369.36 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 316.37 Bn | 3.61 | 7.46 | 308.68 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 164.13 Bn | 37.58 | 2.58 | 152.43 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 54.15 Bn | 11.62 | 1.01 | 46.77 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.41 Bn | -25.11 | — | 44.41 Bn |
| 8 | ONC | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 40.45 Bn | 61.68 | 6.60 | 35.35 Bn |
| 9 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.65 Bn | 15.91 | 4.41 | 21.11 Bn |
| 10 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.87 Bn | 15.92 | 6.62 | 18.21 Bn |
| 11 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.98 Bn | 22.65 | 4.74 | 15.59 Bn |
| 12 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 16.63 | 3.40 | 14.03 Bn |
| 13 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.81 Bn | 17.21 | 6.08 | 13.97 Bn |
| 14 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.88 Bn | 219.20 | 14.30 | 11.57 Bn |
| 15 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.50 Bn | -38.39 | 109.55 | 10.81 Bn |
| 16 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.79 Bn | -70.21 | 18.42 | 10.47 Bn |
| 17 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.29 Bn | -54.70 | — | 10.29 Bn |
| 18 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.76 Bn | -13.31 | 144.25 | 8.60 Bn |
| 19 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 20 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 21 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.84 Bn | 118.50 | 4.70 | 7.18 Bn |
| 22 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.22 Bn | -143.08 | -415.80 | 6.22 Bn |
| 23 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.10 Bn | 44.00 | 13.52 | 5.81 Bn |
| 24 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.74 Bn | -0.12 | — | 5.74 Bn |
| 25 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.71 Bn | -210.49 | 30.66 | 5.39 Bn |
| 26 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.78 Bn | 12.57 | 4.20 | 3.83 Bn |
| 27 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.51 Bn | -22.88 | — | 4.51 Bn |
| 28 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.19 Bn | -11.85 | — | 4.19 Bn |
| 29 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.14 Bn | 11.67 | 3.11 | 3.92 Bn |
| 30 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.96 Bn | -55.30 | — | 3.96 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.95 Bn | -46.92 | — | 3.95 Bn |
| 32 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 33 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | 17.31 | 0.59 | 2.49 Bn |
| 34 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.62 Bn | -77.06 | 5.97 | 3.17 Bn |
| 35 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.18 Bn | -12.25 | 446.55 | 3.18 Bn |
| 36 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.68 Bn | 1.17 | 0.06 | -3.12 Bn |
| 37 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.67 Bn | -63.19 | — | 2.67 Bn |
| 38 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -23.71 | 3.24 | 2.18 Bn |
| 39 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | 13.63 | 2.53 | 1.63 Bn |
| 40 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.40 Bn | -6.86 | — | 2.40 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.35 Bn | -21.69 | 13.81 | 2.35 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.23 Bn | -42.08 | — | 1.92 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.10 Bn | 6.68 | 6.73 | 1.65 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.66 Bn | 173.74 | 16.55 | 1.63 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.57 Bn | 7.98 | 3.74 | 0.99 Bn |
| 46 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -86.49 | 4.43 | 1.36 Bn |
| 47 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.64 | — | 1.43 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -42.65 | 5.18 | 1.34 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.21 Bn | -31.89 | 2.06 | 0.91 Bn |
| 50 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -4.89 | 15.08 | 1.16 Bn |
| 51 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.13 Bn | -23.39 | — | 1.13 Bn |
| 52 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.12 Bn | -5.47 | — | 1.12 Bn |
| 53 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.05 Bn | 71.82 | 1.41 | 0.80 Bn |
| 54 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | -15.69 | 23.80 | 0.80 Bn |
| 55 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -34.03 | — | 0.97 Bn |
| 56 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -11.60 | — | 0.73 Bn |
| 57 | IVA | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | 106.75 | 176.63 | 0.91 Bn |
| 58 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.93 | 9.13 | 0.66 Bn |
| 59 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | 16.09 | 0.95 | 0.62 Bn |
| 60 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.76 Bn | -7.69 | 3.15 | 0.57 Bn |
| 61 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.74 Bn | 12.72 | 5.44 | 0.52 Bn |
| 62 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.67 Bn | -8.52 | 63.63 | 0.67 Bn |
| 63 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.66 Bn | 5.28 | 1.77 | 0.41 Bn |
| 64 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -35.37 | 5.47 | 0.60 Bn |
| 65 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -2.97 | — | 0.60 Bn |
| 66 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -17.33 | 1.88 | 0.55 Bn |
| 67 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -18.87 | — | 0.57 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -2.54 | 5.80 | 0.42 Bn |
| 69 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -15.97 | 348.01 | 0.43 Bn |
| 70 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.51 Bn | -5.34 | 33.78 | 0.32 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -6.71 | — | 0.28 Bn |
| 72 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -12.19 | 860.32 | 0.30 Bn |
| 73 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.30 | 11.27 | 0.42 Bn |
| 74 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.36 Bn | — | — | 0.36 Bn |
| 75 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -5.53 | — | 0.32 Bn |
| 76 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.81 | 0.42 | 0.18 Bn |
| 77 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.17 | 1.49 | 0.15 Bn |
| 78 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -3.11 | — | 0.30 Bn |
| 79 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -39.28 | — | 0.30 Bn |
| 80 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | 0.03 | 0.01 | -10.76 Bn |
| 81 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 82 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.09 | — | 0.29 Bn |
| 83 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.89 | 1.20 | 0.11 Bn |
| 84 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 8.05 | — | 0.08 Bn |
| 85 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.39 | 7.64 | 0.22 Bn |
| 86 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -59.56 | 3.19 | 0.19 Bn |
| 87 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -33.13 | — | 0.22 Bn |
| 88 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.30 | 14.98 | 0.16 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -18.70 | 109.24 | 0.15 Bn |
| 90 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -36.84 | 8.05 | 0.19 Bn |
| 91 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -9.37 | — | 0.17 Bn |
| 92 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.50 | — | 0.13 Bn |
| 93 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.18 Bn | -1.40 | 24.57 | 0.18 Bn |
| 94 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -44.35 | — | 0.17 Bn |
| 95 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.43 | — | 0.14 Bn |
| 96 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -1.81 | — | 0.05 Bn |
| 97 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.45 | — | 0.10 Bn |
| 98 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -2.65 | — | 0.12 Bn |
| 99 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.63 | 3.76 | 0.10 Bn |
| 100 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.40 | 3.24 | 0.10 Bn |
| 101 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.59 | — | 0.09 Bn |
| 102 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -0.78 | 1.63 | 0.06 Bn |
| 103 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.07 Bn |
| 104 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -1.25 | — | 0.08 Bn |
| 105 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -6.96 | 91.57 | 0.08 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 107 | CING | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.17 | — | 0.07 Bn |
| 108 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.10 | — | -0.01 Bn |
| 109 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.01 | — | 0.06 Bn |
| 110 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 122.90 | — | 0.04 Bn |
| 111 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.32 | 1.02 | 0.00 Bn |
| 112 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.05 | — | 0.05 Bn |
| 113 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.26 | 7.34 | 0.05 Bn |
| 114 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -1.48 | 236.40 | 0.05 Bn |
| 115 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.44 | — | 0.04 Bn |
| 116 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.86 | — | 0.04 Bn |
| 117 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.16 | -0.08 Bn |
| 118 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.65 | 8.75 | 0.03 Bn |
| 119 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.57 | — | 0.03 Bn |
| 120 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.25 | 2.88 | 0.02 Bn |
| 121 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -2,145.57 | — | 0.03 Bn |
| 122 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.86 | 78.70 | 0.03 Bn |
| 123 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.08 | 13.00 | 0.03 Bn |
| 124 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -139.51 | 7.89 | 0.02 Bn |
| 125 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.96 | 48.30 | 0.00 Bn |
| 126 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.79 | 0.43 | 0.00 Bn |
| 127 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.87 | 903.73 | 0.02 Bn |
| 128 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | — | 0.02 Bn |
| 129 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.13 | 0.43 | 0.01 Bn |
| 130 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.61 | — | 0.01 Bn |
| 131 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.66 | — | 0.02 Bn |
| 132 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.23 | 0.02 Bn |
| 133 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.44 | — | 0.02 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.72 | — | 0.02 Bn |
| 135 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.51 | — | 0.01 Bn |
| 136 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.54 | — | 0.01 Bn |
| 137 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.36 | -8.81 | -0.01 Bn |
| 138 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.01 Bn |
| 139 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 140 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.42 | — | 0.00 Bn |
| 141 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.01 Bn |
| 142 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.35 | — | 0.00 Bn |
| 143 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.42 | — | 0.01 Bn |
| 144 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.25 | — | 0.01 Bn |
| 145 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.01 | 1,361.75 | 0.00 Bn |
| 146 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.13 | — | 0.00 Bn |
| 147 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.59 | 6.70 | 0.00 Bn |
| 148 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | -3.76 Bn |
| 149 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.22 | — | 0.00 Bn |
| 150 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.27 | 6.65 | -0.01 Bn |
| 151 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 152 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 153 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.15 | — | 0.00 Bn |
| 154 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.94 | 48.63 | 0.00 Bn |
| 155 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | 0.82 | 0.00 Bn |
| 156 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.02 | -0.01 Bn |
| 157 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 158 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 159 | BZYR | Burzynski Research Institute Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | — | 0.00 Bn |
| 160 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 163 | UNH | Unitedhealth Group Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 361.56 Bn | 24.25 | 0.80 | 330.09 Bn |
| 164 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.96 Bn | -64.93 | 6.17 | 184.78 Bn |
| 165 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 141.52 Bn | 32.12 | 11.24 | 133.66 Bn |
| 166 | CVS | CVS HEALTH Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 124.22 Bn | 25.43 | 0.30 | 110.26 Bn |
| 167 | HCA | HCA Healthcare, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 90.36 Bn | 11.53 | 1.16 | 89.35 Bn |
| 168 | HUM | Humana Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 48.73 Bn | 35.52 | 0.33 | 24.86 Bn |
| 169 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.66 Bn | 61.30 | 2.46 | 39.01 Bn |
| 170 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 35.56 Bn | 0.81 | 3.31 | 34.21 Bn |
| 171 | CNC | Centene Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 33.57 Bn | -6.58 | 0.17 | 6.52 Bn |
| 172 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 31.58 Bn | 15.40 | 1.48 | 29.47 Bn |
| 173 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.55 Bn | -31.47 | 24.22 | 26.39 Bn |
| 174 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 24.76 Bn | -20.46 | 2,266.99 | 24.76 Bn |
| 175 | THC | Tenet Healthcare Corp | secondary | H-13 | Healthcare Providers | HG-04 | 22.02 Bn | 9.82 | 1.01 | 19.85 Bn |
| 176 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.72 Bn | -48.01 | 1.34 | 18.83 Bn |
| 177 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.68 Bn | 11.95 | 0.95 | 15.93 Bn |
| 178 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.70 Bn | 41.27 | 4.18 | 14.09 Bn |
| 179 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.78 Bn | 10.12 | 0.84 | 11.09 Bn |
| 180 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.19 | 17.27 | 10.47 Bn |
| 181 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.33 Bn | -27.08 | — | 9.57 Bn |
| 182 | UHS | Universal Health Services Inc | secondary | H-13 | Healthcare Providers | HG-04 | 10.09 Bn | 6.61 | 0.56 | 9.95 Bn |
| 183 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.66 Bn | -743.22 | 4,781.78 | 6.66 Bn |
| 184 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.49 Bn | -39.83 | 1.22 | 6.11 Bn |
| 185 | RDNT | RadNet, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 5.81 Bn | 302.07 | 2.56 | 5.08 Bn |
| 186 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.72 Bn | 26.56 | 1.83 | 5.59 Bn |
| 187 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.06 Bn | -17.61 | — | 5.06 Bn |
| 188 | CON | Concentra Group Holdings Parent, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 4.32 Bn | 21.00 | 1.89 | 4.16 Bn |
| 189 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.27 Bn | -8.34 | 1,183.97 | 4.27 Bn |
| 190 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.79 Bn | -8.23 | 32.36 | 3.08 Bn |
| 191 | OPCH | Option Care Health, Inc. | secondary | H-15 | Healthcare Providers | HG-04 | 3.74 Bn | 17.87 | 0.66 | 3.55 Bn |
| 192 | CRVL | Corvel Corp | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 3.52 Bn | 44.38 | — | 3.17 Bn |
| 193 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.07 Bn | -11.35 | 593.06 | 2.55 Bn |
| 194 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.01 Bn | -16.01 | 6.70 | 2.31 Bn |
| 195 | WRBY | Warby Parker Inc. | secondary | D-10 | Apparel and Luxury | DG-04 | 2.89 Bn | 373.63 | 3.17 | 2.60 Bn |
| 196 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -8.24 | 76.53 | 2.37 Bn |
| 197 | ALHC | Alignment Healthcare, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 2.80 Bn | 68.79 | 0.61 | 2.10 Bn |
| 198 | PRVA | Privia Health Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.60 Bn | 76.97 | 1.10 | 2.19 Bn |
| 199 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -80.02 | — | 2.60 Bn |
| 200 | ACHC | Acadia Healthcare Company, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 2.57 Bn | -2.95 | 0.76 | 2.40 Bn |
| 201 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.56 Bn | -6.66 | 4.79 | 2.21 Bn |
| 202 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.54 Bn | -2.33 | 0.23 | 0.71 Bn |
| 203 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.49 Bn | -21.05 | 1.91 | 2.40 Bn |
| 204 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.39 Bn | -4.08 | — | 2.12 Bn |
| 205 | FMS | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 2.18 Bn | 0.07 | 0.05 | 0.49 Bn |
| 206 | MD | Pediatrix Medical Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.14 Bn | 12.23 | 1.10 | 1.73 Bn |
| 207 | PGNY | Progyny, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 2.08 Bn | 26.44 | 1.59 | 1.84 Bn |
| 208 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.07 Bn | -4.99 | 2,074.50 | 2.07 Bn |
| 209 | ASTH | Astrana Health, Inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.85 Bn | 52.91 | 0.48 | 1.45 Bn |
| 210 | SGRY | Surgery Partners, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 1.82 Bn | 22.26 | 0.54 | 1.61 Bn |
| 211 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | -9.11 | -0.10 | 1.27 Bn |
| 212 | ARDT | Ardent Health, Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.53 Bn | 9.07 | 0.24 | 0.80 Bn |
| 213 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.52 Bn | 14.11 | 1.56 | 1.16 Bn |
| 214 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.26 | 2.10 | 1.21 Bn |
| 215 | HCSG | Healthcare Services Group Inc | secondary | I-27 | Business Services | IG-06 | 1.49 Bn | 12.13 | 0.80 | 1.33 Bn |
| 216 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.48 Bn | -9.03 | — | 1.48 Bn |
| 217 | INNV | InnovAge Holding Corp. | secondary | H-15 | Healthcare Providers | HG-04 | 1.46 Bn | -93.86 | 1.54 | 1.32 Bn |
| 218 | AGL | agilon health, inc. | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 1.45 Bn | -6.23 | 0.24 | 1.26 Bn |
| 219 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.38 Bn | 80.68 | 35.84 | 1.38 Bn |
| 220 | NUTX | Nutex Health Inc. | secondary | H-13 | Healthcare Providers | HG-04 | 1.36 Bn | 4.98 | 1.60 | 1.15 Bn |
| 221 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.35 Bn | -33.54 | — | 1.13 Bn |
| 222 | EYE | National Vision Holdings, Inc. | secondary | D-36 | Retail | DG-10 | 1.34 Bn | 48.14 | 0.68 | 1.30 Bn |
| 223 | UTI | Universal Technical Institute Inc | secondary | D-28 | Consumer Services | DG-09 | 1.19 Bn | 34.68 | 1.35 | 1.02 Bn |
| 224 | USPH | U S Physical Therapy Inc /Nv | secondary | H-14 | Healthcare Providers | HG-04 | 1.19 Bn | 23.82 | 1.46 | 1.16 Bn |
| 225 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | -90.39 | — | 0.96 Bn |
| 226 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.85 Bn | -10.66 | 103.24 | 0.85 Bn |
| 227 | WOOF | Petco Health & Wellness Company, Inc. | secondary | S-13 | Staples Retail | SG-06 | 0.71 Bn | 606.69 | 0.12 | 0.55 Bn |
| 228 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -361,802.81 | — | 0.35 Bn |
| 229 | STLN | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.61 Bn | -19.98 | 1.04 | 0.57 Bn |
| 230 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.59 Bn | 1,193.73 | 6.18 | 0.49 Bn |
| 231 | KIDS | Orthopediatrics Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.54 Bn | -13.66 | 2.15 | 0.50 Bn |
| 232 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -7.68 | 23.08 | 0.24 Bn |
| 233 | EVH | Evolent Health, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.48 Bn | -0.93 | 0.23 | 0.34 Bn |
| 234 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -80.05 | 610.85 | 0.34 Bn |
| 235 | SRTA | Strata Critical Medical, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.46 Bn | 11.52 | 1.81 | 0.44 Bn |
| 236 | MCTA | Charming Medical Ltd | secondary | D-29 | Consumer Services | DG-09 | 0.45 Bn | -42,242.59 | 92.66 | 0.44 Bn |
| 237 | SBC | SBC Medical Group Holdings Inc | secondary | H-14 | Healthcare Providers | HG-04 | 0.44 Bn | 11.66 | 2.51 | 0.26 Bn |
| 238 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.48 | 44.22 | 0.35 Bn |
| 239 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.57 | 43.22 | 0.23 Bn |
| 240 | AUNA | Auna S.A. | secondary | H-13 | Healthcare Providers | HG-04 | 0.40 Bn | 12.92 | 0.09 | 0.24 Bn |
| 241 | CYH | Community Health Systems Inc | secondary | H-13 | Healthcare Providers | HG-04 | 0.39 Bn | 2.36 | 0.03 | 0.24 Bn |
| 242 | SWKHL | SWK Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -332.50 | 7.43 | 0.27 Bn |
| 243 | TBI | TrueBlue, Inc. | secondary | I-25 | Business Services | IG-06 | 0.30 Bn | -5.30 | 0.18 | 0.28 Bn |
| 244 | INFU | InfuSystem Holdings, Inc | secondary | H-14 | Healthcare Providers | HG-04 | 0.24 Bn | 28.58 | 1.70 | 0.24 Bn |
| 245 | FTH | Faeth Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.14 | — | 0.22 Bn |
| 246 | STIM | Neuronetics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.20 Bn | -6.27 | 1.28 | 0.18 Bn |
| 247 | AIRS | Airsculpt Technologies, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.18 Bn | -15.30 | 1.19 | 0.16 Bn |
| 248 | NAKA | Nakamoto Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 0.17 Bn | -0.40 | 4.23 | 0.15 Bn |
| 249 | TNYA | Tenaya Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.47 | 113.89 | 0.15 Bn |
| 250 | IFRX | InflaRx N.V. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -3.74 | 3.44 | -0.03 Bn |
| 251 | SPRB | Spruce Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.92 | — | 0.14 Bn |
| 252 | NRXP | NRX Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -6.21 | 38.08 | 0.10 Bn |
| 253 | JYNT | JOINT Corp | secondary | H-14 | Healthcare Providers | HG-04 | 0.12 Bn | 31.39 | 2.01 | 0.10 Bn |
| 254 | SLQT | SelectQuote, Inc. | secondary | F-16 | Insurance | FG-04 | 0.10 Bn | -8.79 | 0.06 | 0.08 Bn |
| 255 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.31 | 1.25 | -0.11 Bn |
| 256 | PYPD | PolyPid Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 2.73 | — | 0.08 Bn |
| 257 | AIFC | AI Financial Corp | secondary | T-54 | Fintech | TG-09 | 0.08 Bn | -0.09 | 3.83 | 0.07 Bn |
| 258 | MYO | Myomo, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -4.95 | — | 0.04 Bn |
| 259 | RYOJ | rYojbaba Co., Ltd. | secondary | H-14 | Healthcare Providers | HG-04 | 0.05 Bn | -47.64 | 6.80 | 0.05 Bn |
| 260 | PTN | Palatin Technologies Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -8.11 | 3.95 | 0.05 Bn |
| 261 | BTMD | biote Corp. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | 6.80 | 0.24 | 0.03 Bn |
| 262 | DCGO | DocGo Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.04 Bn | -0.19 | 0.14 | 0.01 Bn |
| 263 | APLM | Apollomics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -5.27 | 7.40 | 0.04 Bn |
| 264 | PIII | P3 Health Partners Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -0.12 | 0.02 | 0.01 Bn |
| 265 | BETRF | BetterLife Pharma Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -32.35 | — | 0.03 Bn |
| 266 | KAPA | Kairos Pharma, LTD. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.09 | 0.34 | 0.02 Bn |
| 267 | EUDA | EUDA Health Holdings Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.03 Bn | -9.19 | 3.78 | 0.03 Bn |
| 268 | ETST | Earth Science Tech, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 6.76 | 0.73 | 0.02 Bn |
| 269 | TANAF | Tian'an Technology Group Ltd | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | — | 37.78 | 0.02 Bn |
| 270 | SY | So-Young International Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -0.59 | 0.09 | -0.09 Bn |
| 271 | CCM | Concord Medical Services Holdings Ltd | secondary | H-13 | Healthcare Providers | HG-04 | 0.02 Bn | -0.29 | 0.31 | -0.02 Bn |
| 272 | AAQL | Antiaging Quantum Living Inc. | secondary | T-47 | Internet Platforms | TG-08 | 0.02 Bn | -19.44 | 13.50 | 0.02 Bn |
| 273 | MDBH | MDB Capital Holdings, LLC | secondary | F-17 | Capital Markets | FG-05 | 0.02 Bn | -1.30 | — | 0.01 Bn |
| 274 | QCLS | Q/C Technologies, Inc. | secondary | T-01 | Semiconductors | TG-01 | 0.02 Bn | -1.31 | — | 0.02 Bn |
| 275 | LDDD | Longduoduo Co Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.02 Bn | -35.14 | 7.18 | 0.01 Bn |
| 276 | KPEA | Kun Peng International Ltd. | secondary | D-32 | Retail | DG-10 | 0.01 Bn | -14.13 | 24.95 | 0.01 Bn |
| 277 | RKTO | Rocket One Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.07 | — | 0.01 Bn |
| 278 | PFHO | Pacific Health Care Organization Inc | secondary | H-18 | Healthcare Payers and Distributors | HG-05 | 0.01 Bn | 13.47 | 2.05 | 0.00 Bn |
| 279 | ADIA | Adia Nutrition, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -44.03 | 69.62 | 0.01 Bn |
| 280 | AMS | American Shared Hospital Services | secondary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | -3.76 | 0.33 | 0.00 Bn |
| 281 | XWEL | XWELL, Inc. | secondary | D-29 | Consumer Services | DG-09 | 0.01 Bn | -0.25 | 0.29 | 0.00 Bn |
| 282 | BMGL | Basel Medical Group Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.01 Bn | 20.47 | — | 0.01 Bn |
| 283 | HLYK | HealthLynked Corp | secondary | T-27 | Vertical Software | TG-05 | 0.01 Bn | -1.49 | 5.43 | 0.01 Bn |
| 284 | INM | InMed Pharmaceuticals Inc. | secondary | M-02 | Chemicals | MG-01 | 0.01 Bn | -0.67 | — | 0.00 Bn |
| 285 | LFST | LifeStance Health Group, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.09 | 0.00 | -0.22 Bn |
| 286 | TPST | Tempest Therapeutics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.28 | — | 0.00 Bn |
| 287 | CDIX | Cardiff Lexington Corp | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -1.10 | — | 0.01 Bn |
| 288 | BTAI | BioXcel Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | 4.64 | 0.00 Bn |
| 289 | VVOS | Vivos Therapeutics, Inc. | secondary | H-09 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.12 | 0.15 | 0.00 Bn |
| 290 | IVF | INVO Fertility, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.49 | 0.45 | 0.00 Bn |
| 291 | MEDS | DataMeds AI, Inc. | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 0.00 Bn | -0.03 | 0.14 | 0.00 Bn |
| 292 | VYCO | Vycor Medical Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -5.21 | 1.11 | 0.00 Bn |
| 293 | AGSS | Ameriguard Security Services, Inc. | secondary | I-28 | Business Services | IG-06 | 0.00 Bn | 10.85 | 0.08 | 0.00 Bn |
| 294 | RMTG | Regenerative Medical Technology Group Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.13 | 0.15 | 0.00 Bn |
| 295 | FCHS | First Choice Healthcare Solutions, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 296 | ZCMD | Zhongchao Inc. | secondary | T-27 | Vertical Software | TG-05 | 0.00 Bn | -0.01 | 0.00 | -0.01 Bn |
| 297 | NIVF | NewGenIvf Group Ltd | secondary | H-14 | Healthcare Providers | HG-04 | 0.00 Bn | 0.00 | 0.00 | 0.00 Bn |